Linfomas
GLUN
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicacions en col·laboració amb investigadors/es de University of Texas MD Anderson Cancer Center (14)
2024
-
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)
Blood cancer discovery, Vol. 5, Núm. 1, pp. 21-33
2022
-
IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S387
-
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
The Lancet Oncology, Vol. 23, Núm. 8, pp. 1055-1065
2019
-
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Nature Communications, Vol. 10, Núm. 1
2018
-
Richter transformation driven by Epstein–Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia
Journal of Pathology, Vol. 245, Núm. 1, pp. 61-73
2017
-
The dual Syk/JAK inhibitor cerdulatinib antagonizes b-cell receptor and microenvironmental signaling in chronic lymphocytic leukemia
Clinical Cancer Research, Vol. 23, Núm. 9, pp. 2313-2324
2016
-
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
Cancer, Vol. 122, Núm. 14, pp. 2178-2185
-
Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients
Acta Haematologica, Vol. 136, Núm. 2, pp. 76-84
2015
2013
-
MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma
British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347
2012
-
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung
Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1129-1136
2011
-
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas
PLoS ONE, Vol. 6, Núm. 10
2009
-
Estradiol induces type 8 17β-hydroxysteroid dehydrogenase expression: Crosstalk between estrogen receptor α and C/EBPβ
Journal of Endocrinology, Vol. 200, Núm. 1, pp. 85-92
-
Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide
Leukemia and Lymphoma, Vol. 50, Núm. 8, pp. 1283-1289